Science Corp raises $230M as it races to bring its brain implant to market

Science Corporation, founded by Neuralink co-founder Max Hodak, has raised $230M in a Series C round at a $1.25B post-money valuation. The company is focused on PRIMA, a rice-grain-sized retinal implant that works with camera-equipped glasses to restore vision in patients with advanced macular degeneration. In trials across 47 patients, 80% showed meaningful improvement in visual acuity. Science Corp. has submitted a CE mark application in the EU and expects approval by mid-2026, which would make it the first BCI company with a product on the market. The funding will also support a biohybrid neural interface program and a new organ preservation platform called Vessel. Total funding now stands at $490M.